The values of AHCY and CBS promoter methylation on the diagnosis of cerebral infarction in Chinese Han population.
Xiaodong LiShufang BuRan Ran PanCong ZhouKun QuXiuru YingJie ZhongJianhao XiaoQian YuanSimiao ZhangLaura TiptonYunliang WangYouping DengShiwei DuanPublished in: BMC medical genomics (2020)
Our study suggests that hypomethylation of the CBS promoter may be closely related to the risk of cerebral infarction and may be used as a non-invasive diagnostic biomarker for cerebral infarction.